Dacarbazine
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.
🧴 Clinical Application
Administer intravenously by slow infusion over 15 to 30 minutes diluted in 5% Dextrose or 0.9% NaCl. Protect solution from light during administration. Administer antiemetics beforehand (highly emetogenic).
⚠️ Side Effects
Common: Severe acute nausea and vomiting (>90% of patients), bone marrow depression (leukopenia, thrombocytopenia nadir at 21-25 days), flu-like syndrome, alopecia, local burning/pain along the infusion vein. Rare/Severe: Hepatic vein thrombosis / hepatic necrosis (Budd-Chiari syndrome), anaphylaxis, and tissue necrosis upon extravasation.
🛡️ Safety Warnings
Black Box Warning: Severe bone marrow suppression and hepatic necrosis with vascular thrombosis (fatal Budd-Chiari syndrome). Highly emetogenic; pre-medicate aggressively. Extravasation causes severe pain and tissue damage. Protect infusion line from direct sunlight.
Jan Aushadhi Products containing Dacarbazine
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Dacarbazine.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Dacarbazine Injection 200mg | VIAL | ₹176.25 | Dacarex, DABAZ | ₹172.67 | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Dacarbazine generics.